(E)-1-(1-butylphthalazin-2(1H)-yl)-3-(5-((2,4-diaminopyrimidin-5-yl)methyl)-2,3-dimethoxyphenyl)prop-2-en-1-one

ID: ALA1652304

Chembl Id: CHEMBL1652304

PubChem CID: 53325619

Max Phase: Preclinical

Molecular Formula: C28H32N6O3

Molecular Weight: 500.60

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCC[C@H]1c2ccccc2C=NN1C(=O)/C=C/c1cc(Cc2cnc(N)nc2N)cc(OC)c1OC

Standard InChI:  InChI=1S/C28H32N6O3/c1-4-5-10-23-22-9-7-6-8-20(22)17-32-34(23)25(35)12-11-19-13-18(15-24(36-2)26(19)37-3)14-21-16-31-28(30)33-27(21)29/h6-9,11-13,15-17,23H,4-5,10,14H2,1-3H3,(H4,29,30,31,33)/b12-11+/t23-/m0/s1

Standard InChI Key:  VMZJLCOUDXEVIH-RGPPVUSESA-N

Associated Targets(non-human)

dfrA Dihydrofolate reductase (135 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 500.60Molecular Weight (Monoisotopic): 500.2536AlogP: 4.37#Rotatable Bonds: 9
Polar Surface Area: 128.95Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.16CX LogP: 4.74CX LogD: 4.55
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.42Np Likeness Score: -0.04

References

1. Bourne CR, Bunce RA, Bourne PC, Berlin KD, Barrow EW, Barrow WW..  (2009)  Crystal structure of Bacillus anthracis dihydrofolate reductase with the dihydrophthalazine-based trimethoprim derivative RAB1 provides a structural explanation of potency and selectivity.,  53  (7): [PMID:19364848] [10.1128/aac.01666-08]

Source